Somatix lives on

With the loss of Hoechst Marion Roussel Inc. as a partner for its AIDS gene therapy program, Cell Genesys Inc.'s clinical programs now consist entirely of the GVAX cancer vaccines it acquired through its purchase of Somatix Therapy

Read the full 389 word article

How to gain access

Continue reading with a
two-week free trial.